adenylyl imidodiphosphate has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, WG; Gong, LH; Heng, WJ; Li, Y; Shi, YH; Wang, YX; You, JF; Zhong, HH | 1 |
| He, C; Li, H; Zheng, J | 1 |
2 other study(ies) available for adenylyl imidodiphosphate and Cancer of Prostate
| Article | Year |
|---|---|
[P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
Topics: Adenylyl Imidodiphosphate; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Purinergic P2 Receptor Agonists; S Phase; Signal Transduction | 2007 |
[Mechanism of the activation of extracellular signal-regulated kinase (ERK) in prostate cancer cell lines with different metastatic potential].
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Enzyme Activation; Humans; Male; MAP Kinase Kinase Kinase 1; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Receptors, Purinergic P2; Tetradecanoylphorbol Acetate | 2001 |